GSK plc (GSK)

NYSE: GSK · Pharmaceutical Preparations · London · filing with the SEC since 2001

Grade6.2

◀ Past 7.2● Present 6.4▶ Future 4.9

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In millions of pounds sterling (GBP), as filed; per-share figures in pounds sterling; share counts in millions.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 6, 2026	Mar 3, 2025	Mar 5, 2024	Mar 10, 2023	Mar 8, 2022	Mar 12, 2021	Mar 6, 2020	Mar 15, 2019	Mar 16, 2018	Mar 17, 2017
Revenue	32,667	31,376	30,328	29,324	24,696^r	24,354^r	33,754	30,821	30,186	27,889
Cost of revenue	9,017	9,048	8,565	9,554	8,163^r	7,929^r	11,863	10,241	10,342	9,290
Gross profit	23,650	22,328	21,763	19,770	16,533^r	16,425^r	21,891	20,580	19,844	18,599
Research and development	7,525	6,401	6,223	5,488	5,019^r	4,793^r	4,568	3,893	4,476	3,628
Selling, general and administrative	9,088	11,015	9,385	8,372	7,070^r	7,437^r	11,402	9,915	9,672	9,366
Sales and marketing	202	198	199	192	169^r	176^r	393	389	405	395
Operating income	7,932	4,021	6,745	6,433	4,357^r	5,979^r	6,961	5,483	4,087	2,598
Finance costs	701	669	792	879	769^r	874^r	912	798	734	736
Finance income	169	122	115	76	14^r	32^r	98	81	65	72
Share of profit of equity-method investments	1	-3	-5	-2	33	33	74	31	13	5
Income before income taxes	7,401	3,477	6,064	5,628	3,599^r	5,170^r	6,221	4,800	3,525	1,939
Income tax expense	1,112	526	756	707	83^r	67^r	953	754	1,356	877
Income from continuing operations	·	2,951	5,308	4,921	3,516	5,103	·	·	·	·
Income from discontinued operations	·	0	0	10,700	1,580	1,285	·	·	·	·
Net income	6,289	2,951	5,308	15,621	5,096	6,388	5,268	4,046	2,169	1,062
Net income to non-controlling interests	573	376	380	665	711	639	623	423	637	150
Net income to shareholders	5,716	2,575	4,928	14,956	4,385	5,749	4,645	3,623	1,532	912
Earnings per share, basic	1.411	0.632	1.216	3.714	1.096^r	1.444^r	1.1737^b	0.9212^b	0.3925^b	0.235^b
Earnings per share, diluted	1.388	0.622	1.199	3.662	1.082^r	1.426^r	1.1575^b	0.9112^b	0.3875^b	0.2325^b
Weighted average shares, basic	4,051.0	4,077.0	4,052.0	4,026.0	4,003.0^r	3,981.0^r	3,957.6^b	3,931.2^b	3,908.8^b	3,888.0^b
Weighted average shares, diluted	4,117.0	4,142.0	4,111.0	4,084.0	4,052.0^r	4,030.0^r	4,012.8^b	3,976.8^b	3,952.8^b	3,927.2^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 4-for-5 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:Revenue

Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales

Gross profit revenue less the cost of what it soldifrs-full:GrossProfit

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense

Sales and marketing the cost of finding and serving customersifrs-full:DistributionCosts

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:FinanceCosts

Finance income what its cash and investments earnedifrs-full:FinanceIncome

Share of profit of equity-method investments its share of companies it partly ownsifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations

Income from discontinued operations profit or loss from businesses it sold or closedifrs-full:ProfitLossFromDiscontinuedOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton GSK · research, not advice